Nanomedicine and Nanoscale Delivery (Focus Group – NND)
MUHAMMAD TAUSIF, MS (he/him/his)
Ph.D. Candidate
DGIST
Daegu, Taegu-jikhalsi, Republic of Korea
Previously, we developed an ultrasoft implantable drug delivery device for long-term controlled release with reduced foreign body responses vs. conventional reservoir-based systems [1]. However, rhodamine B was the only compound released through native polydimethylsiloxane (PDMS) membranes, limiting broader applicability. Subsequent integration of porous PDMS patches enabled release of clinically relevant drugs, including doxorubicin, but PDMS hydrophobicity caused delayed onset and inconsistent release [2]. To address this, we developed an amphiphilic porous PDMS membrane [3]. Here, we evaluate its long-term in vitro release kinetics integrated into a soft drug delivery device.